Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients

Vaccine

Volumn 15, Issue 15, 1997, Pages 1675-1679

  Conne, Pierre ^a   Gauthey, Laurent ^a   Vernet, Philippe ^a   Althaus, Beat ^b   Que, John U ^b   Finkel, Beatriz ^b   Glück, Reinhard ^b   Cryz Jr , Stanley J ^b,c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Berna Biotech AG   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Influenza; Subunit; Vaccine; Virosome

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; LIPOSOME; PHOSPHATIDYLETHANOLAMINE; TRIPLE VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GERIATRIC PATIENT; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; DOUBLE-BLIND METHOD; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNIZATION; INFLUENZA VACCINES; MALE; MIDDLE AGED;

EID: 0030812765     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00087-X     Document Type: Article

References (31)

1. Arden, N.H., Patriarca, P.A. and Kendal, A.P. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In: Options for the Control of Influenza (Eds Kendal, A.P. and Patriarca, P.A.). Alan R. Liss, New York, 1986, pp. 155-168.
2. Arden, N.H., Patriarca, P.A., Lui, K.J., Harmon, M.W., Brandon, F. and Kendal, A.P. Safety and imrnunogenicity of a 45 μg supplemental dose of inactivated split-virus influenza B vaccine in the elderly. Journal of Infectious Diseases 1986, 153, 805-810.
3. Center for Disease Control (Atlanta). Influenza vaccination levels, 1989-1991. JAMA 1992, 268, 2360.
4. Cryz Jr., S.J., Que, J.U. and Glück, R. A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans. Vaccine, 1996, 4, 1381.
5. Denis, F., Mounier, M., Hessel, L., Michel, J.P., Gualde, N., Dubois, F., Barin, F. and Goudeau, A. Hepatitis B vaccination in the elderly. Journal of Infectious Diseases 1984, 149, 1019-1023.
6. Editorial. Prevention and control of influenza. Part I: vaccines. JAMA 1989, 261, 3220-3222.
7. Ershler, W.B. Influenza vaccination in the elderly: can efficacy be enhanced?. Geriatrics 1988, 43, 79-83.
8. European Council (Strasbourg) (Ed), European Pharmacopoeia, 2nd edn. Maisonneuve, Sainte-Ruffine, France, 1980
9. Feery, B.J., Evered, M.G. and Morrison, E. I. Different protection rates in various groups of volunteers given subunit influenza vaccine in 1976. Journal of Infectious Diseases 1979, 139, 241-327.
10. Glück, R., Mischler, R., Brantschen, S., Just, M., Althaus, B. and Cryz, S.J. Jr. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A. Journal of Clinical Investigation 1992, 90, 2491-2495.
11. Glück, R., Mischler, R., Finkel, B., Que, J.U., Scarpa, B. and Cryz, S.J. Jr. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet 1994, 344, 160-163.
12. Huang, Y.-P., Pechere, J.-C., Michel, M., Gauthey, L., Loreto, M., Curran, J.A. and Michel, J.-P. In vitro T cell activation, in vitro defective IL-2 secretion, and responses to influenza vaccination in elderly women. Journal of Immunology 1992, 148, 715-722.
13. Huang, Y.-P., Gauthey, L. and Michel, et al. The relationship between influenza vaccine-induced specific antibody responses and vaccine-induced nonspecific autoantibody responses in healthy older women. Journal of Gerontology 1992, 47, M50-55.
14. Govaert, T.M.E., Sprenger, M.J.W., Dinant, G.J., Aretz, K., Masurel, N. and Knottnerus, J.A. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 1994, 12, 1185-1189.
15. Influenza and pneumococcal vaccination coverage levels among persons aged > 65 years - United States, 1973-1993. MMWR 1995, 44, 506-515
16. Lennox, I.M., Macphee, G.J.A., McAlpine, C.H., Cameron, S.O., Leask, B.G.S. and Somerville, R.G. Use of influenza vaccine in long-stay geriatric units. Age and Ageing 1990, 19, 169-172.
17. Lui, K.J. and Kendal, A.P. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. American Journal of Public Health 1987, 77, 712-716.
18. McBean, A.M., Babish, J.D. and Warren, J.L. The impact and cost of influenza in the elderly. Archives of International Medicine 1993, 13, 2105-2111.
19. McElhaney, J.E., Meneilly, G.S., Lechelt, K.E. and Bleackley, R.C. Split-virus vaccines: do they provide adequate immunity in the elderly?. Journal of Gerontology 1994, 49, M37-M43.
20. McMichael, A.F., Gotch, F.M., Noble, G.R. and Beare, P.S. Cytotoxic T-cell immunity to influenza. New England Journal of Medicine 1983, 309, 13-17.
21. Monto, A.S. Influenza vaccines for the elderly. New England Journal of Medicine 1994, 331, 807-808.
22. Mullooly, J.P., Bennett, M.D. and Hornbrook, M.C. et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Annals of International Medicine 1994, 121, 947-952.
23. Nguyen-Van-Tam, J.S. and Nicholson, K.G. Influenza immunizations; vaccine offer, request and uptake in high risk patients during the 1991/2 season. Epidemiology of Infection 1993, 111, 347-355.
24. Palache, A.M., Beyer, W.E.P. and Sprenger, M.J.W. et al. Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multicentre, dose response study in elderly nursing home residents and young volunteers. Vaccine 1993, 11, 3-9.
25. Phair, J., Kaufman, C.A., Bjornson, A., Adams, L. and Linnemann, C. Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. Journal of Laboratory and Clinical Medicine 1978, 92, 822-828.
26. Sprenger, M.J., Mulder, P.G., Beyer, W.E. and Masurel, N. Influenza: relation of mortality to morbidity parameters -Netherlands, 1970-1989. International Journal of Epidemiology 1991, 20, 1118-1124.
27. Strasbourg, M.A., Greenland, S., Sorvillo, F.J., Lieb, L.E. and Itabel, L.A. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986, 4, 38-44.
28. Tillet, H.E., Smith, J.W. and Gooch, C.D. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. International Journal of Epidemiology 1983, 12, 344-352.
29. Treanor, J.J., Mattison, R. and Dumyati, G. et al. Protective efficacy of a live intranasal and inactivated influenza virus vaccines in the elderly. Annals of International Medicine 1992, 117, 625-633.
30. Wharton, S.A., Martin, S.R., Ruigrok, R.W.H., Skehel, J.J. and Wiley, D.C. Membrane fusion-peptide analogues of influenza virus hemagglutinin. Journal of General Virology 1988, 69, 1847-1857.
31. Wiley, D.C. and Skehel, J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annual Review of Biochemistry 1987, 56, 365-394.